# Project Current Audit - PsychRx

## Date

2026-06-30

## Scope

Audit of current project navigation after completion of A03-030.

## Completed Program A03 Phase 2 Missions

- A03-011 through A03-020.

## Completed Program A03 Phase 3 Missions

- A03-021 - Scientific Drug Profile Initialization.
- A03-022 - Mechanism of Action Modeling.
- A03-023 - Receptor and Neurotransmitter Modeling.
- A03-024 - Pharmacokinetic Modeling.
- A03-025 - Pharmacodynamic Modeling.
- A03-026 - Indication Modeling.
- A03-027 - Posology Modeling.
- A03-028 - Contraindication Modeling.
- A03-029 - Safety Modeling.
- A03-030 - Phase 3 Sprint 1 Baseline.

## Current Mission State

`governance/execution/NEXT_MISSION.md` correctly points to:

```text
CTO_GATE_REVIEW - A03_PHASE_3_SPRINT_1_BASELINE_REVIEW
```

## Most Recent Incoming Prompt

An A03-025 prompt was received on 2026-07-01.

It was initially not executed because A03-022, A03-023 and A03-024 were not complete.

After subsequent execution cycles, A03-025 through A03-030 were completed, so the project is now at CTO gate review.

Block report:

```text
docs/A03_025_BLOCKED_BY_SEQUENCE.md
```

## Current Status

Program A03 Phase 2 is complete.

ADR 0045 refactored Phase 3 from granular metadata repetition into scientific-domain modeling.

A03-021 created structural Scientific Drug Profile shells only.

A03-022 through A03-029 created structural mechanism, receptor/neurotransmitter, PK, PD, indication, posology, contraindication and safety shells only.

## Gate Result

All 8 Phase 2 gates are approved.

A03-021 structural validation passed.

A03-022 through A03-030 structural validations passed.

## Still Prohibited

- therapeutic recommendation;
- prescription;
- runtime consumption;
- dose recommendations;
- indication recommendations;
- safety claims without future field-level source validation;
- evidence grading without future authorized mission.

## Final Audit Decision

The project is coherent after A03-030. The next required project action is CTO gate review before A04 or any new extraction phase.

